Connection

GUILHERME GODOY to Prostatic Neoplasms

This is a "connection" page, showing publications GUILHERME GODOY has written about Prostatic Neoplasms.
Connection Strength

1.564
  1. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. J Urol. 2012 Jun; 187(6):2082-6.
    View in: PubMed
    Score: 0.197
  2. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. Eur Urol. 2011 Aug; 60(2):195-201.
    View in: PubMed
    Score: 0.181
  3. Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy. Urology. 2011 Mar; 77(3):669-74.
    View in: PubMed
    Score: 0.180
  4. Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen? Urol Oncol. 2011 Jul-Aug; 29(4):388-92.
    View in: PubMed
    Score: 0.165
  5. Site of positive surgical margins influences biochemical recurrence after radical prostatectomy. BJU Int. 2009 Dec; 104(11):1610-4.
    View in: PubMed
    Score: 0.162
  6. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy? Urology. 2009 Jul; 74(1):167-70.
    View in: PubMed
    Score: 0.161
  7. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.052
  8. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8.
    View in: PubMed
    Score: 0.051
  9. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011 Aug; 60(2):205-10.
    View in: PubMed
    Score: 0.046
  10. Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology. 2010 Sep; 76(3):689-92.
    View in: PubMed
    Score: 0.043
  11. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol. 2010 Jul; 184(1):143-8.
    View in: PubMed
    Score: 0.043
  12. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection. BJU Int. 2010 Aug; 106(3):391-6.
    View in: PubMed
    Score: 0.042
  13. Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. J Urol. 2010 Mar; 183(3):984-9.
    View in: PubMed
    Score: 0.042
  14. Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy. Can J Urol. 2009 Jun; 16(3):4655-9.
    View in: PubMed
    Score: 0.040
  15. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int. 2009 Jul; 104(2):195-9.
    View in: PubMed
    Score: 0.040
  16. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy. J Urol. 2009 Mar; 181(3):1082-9; discussion 1089-90.
    View in: PubMed
    Score: 0.039
  17. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol. 2009 Feb; 181(2):731-5.
    View in: PubMed
    Score: 0.039
  18. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort. Urology. 2009 Feb; 73(2):351-4; discussion 354-5.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.